These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Point-of-care N-terminal pro B-type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice. Lu TL, Côté E, Kuo YW, Wu HH, Wang WY, Hung YW. J Vet Intern Med; 2021 Jul; 35(4):1663-1672. PubMed ID: 33993546 [Abstract] [Full Text] [Related]
26. Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy. Sahin I, Gungor B, Ozkaynak B, Uzun F, Küçük SH, Avci II, Ozal E, Ayça B, Cetın S, Okuyan E, Dinckal MH. Clin Cardiol; 2017 Jan; 40(1):32-37. PubMed ID: 27768229 [Abstract] [Full Text] [Related]
29. [Influencing factors for the plasma concentration of N-terminal brain natriuretic peptide precursor in patients with heart failure due to various heart diseases]. Wei BQ, Zhang J, Yang YJ, Zhang YH, Huang XH, Yu LT, Zhou Q, Tan HQ, Yang YM, Wang GG, Zhu J. Zhonghua Yi Xue Za Zhi; 2011 Oct 18; 91(38):2683-7. PubMed ID: 22321977 [Abstract] [Full Text] [Related]
30. The left atrial phasic functions and the relationship with plasma N-terminal pro-B-type natriuretic peptide levels and symptomatic states in patients with hypertrophic cardiomyopathy. Tülüce K, Yakar Tülüce S, Yavuzgil O, İsayev E, Bilgin M, Akyıldız Akçay F, Nalbantgil S, Özerkan F. Anadolu Kardiyol Derg; 2014 Dec 18; 14(8):719-27. PubMed ID: 25188761 [Abstract] [Full Text] [Related]
32. Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy. Hanås S, Larsson A, Rydén J, Lilliehöök I, Häggström J, Tidholm A, Höglund K, Ljungvall I, Holst BS. J Feline Med Surg; 2022 Oct 18; 24(10):e370-e379. PubMed ID: 36073987 [Abstract] [Full Text] [Related]
34. Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease. Lalor SM, Connolly DJ, Elliott J, Syme HM. J Vet Cardiol; 2009 May 18; 11 Suppl 1():S71-9. PubMed ID: 19398225 [Abstract] [Full Text] [Related]
35. Assessment of circulating N-terminal pro B-type natriuretic peptide concentration to differentiate between cardiac from noncardiac causes of pleural effusion in cats. Hassdenteufel E, Henrich E, Hildebrandt N, Stosic A, Schneider M. J Vet Emerg Crit Care (San Antonio); 2013 May 18; 23(4):416-22. PubMed ID: 23859335 [Abstract] [Full Text] [Related]
36. Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non-cardiac causes of respiratory distress. Connolly DJ, Soares Magalhaes RJ, Fuentes VL, Boswood A, Cole G, Boag A, Syme HM. J Vet Cardiol; 2009 May 18; 11 Suppl 1():S41-50. PubMed ID: 19394286 [Abstract] [Full Text] [Related]
38. Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy. Hori Y, Iguchi M, Heishima Y, Yamashita Y, Nakamura K, Hirakawa A, Kitade A, Ibaragi T, Katagi M, Sawada T, Yuki M, Kanno N, Inaba H, Isayama N, Onodera H, Iwasa N, Kino M, Narukawa M, Uchida S. J Vet Intern Med; 2018 May 18; 32(3):922-929. PubMed ID: 29660794 [Abstract] [Full Text] [Related]
39. N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy. Wu G, Liu J, Wang S, Yu S, Zhang C, Wang D, Zhang M, Yang Y, Kang L, Zhao S, Hui R, Zou Y, Wang J, Song L. Heart; 2021 Oct 18; 107(19):1576-1583. PubMed ID: 33361398 [Abstract] [Full Text] [Related]